Genetesis Announces Close of $17.5 Million Series C Financing

Genetesis, the market leader in next-generation biomagnetic imaging, has announced that it has closed $17.5 million in Series C Financing. The round was led...

Ossiform raises capital through West Hill

Ossiform, We Print Bone™, is pleased to announce that it has completed a £6 million capital raise through West Hill Capital. Ossiform has developed a...

Volumina Medical closes its Series A funding

Clinique La Prairie and Skyviews Life Science Ltd are among the new investors Volumina Medical, a spin-off from the Swiss Federal Institute of Technology in...

Wearable Medical Devices Company Acurable Raises €11m in Series A Funding Round

● This investment will allow Acurable to build out its distribution network to launch its home sleep testing device AcuPebble SA100 across major European...

CXL Ophthalmics Announces $32 Million Series A Investment Round Led by AXA IM Alts, Through its Global Health Private Equity Strategy

CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, announced it has raised a $32 million Series A funding round...

Bionic Clothing Innovator CIONIC Secures $12.5M Series A Funding to Revolutionize Human Mobility

CIONIC, the innovative bionic clothing company behind the breakthrough Cionic Neural Sleeve, announced a $12.5M Series A financing. The round was led by...

Mental health company for seniors launches with $32M seed round

Rippl's mental health offering aims to provide seniors with 24/7 access to care. Rippl, a company focused on providing mental health solutions to seniors with...

Optellum, AI Lung Cancer Diagnosis Innovator, Secures $14M Series A Funding to Accelerate Expansion

Lead investor Mercia, alongside Intuitive Ventures and Black Opal, invests in Optellum's pioneering AI-powered lung-health technology  Optellum, an Oxford-based medtech company that provides a breakthrough AI platform to...

Leuko raises Series A funds to validate WBC monitoring solution

The latest funding will expedite the clinical trials necessary for the solution to obtain regulatory clearance. Leuko has raised Series A funding worth $5m for the validation...

Latest articles